Stada Arzneimittel AG | Ownership
Companies that own Stada Arzneimittel AG
Elliott Management Corp.
9,500,142
15.24%
0
4.2%
02/09/2018
Norges Bank Investment Management
1,859,848
2.98%
-22,566
0.03%
08/24/2017
UBS Asset Management (UK) Ltd.
1,832,351
2.94%
-737,501
0.18%
07/18/2017
The Vanguard Group, Inc.
589,914
0.95%
15,231
0%
07/31/2018
Azimut Capital Management SGR SpA
534,000
0.86%
534,000
0.78%
06/30/2017
TBF Global Asset Management GmbH
305,000
0.49%
205,000
2.37%
11/30/2017
Lyxor Asset Management SAS
290,430
0.47%
290,430
0.13%
08/16/2018
BlackRock Fund Advisors
244,603
0.39%
143
0%
09/06/2018
BC Investment Management Corp.
162,200
0.26%
0
0.04%
03/31/2017
GAM Capital Management (Switzerland) AG (Lugano Branch)
161,241
0.26%
161,241
1.33%
07/31/2018
| Address |
Stadastrasse 2-18
Bad Vilbel Hessen 61118
Germany
|
|
Employees
|
- |
| Website |
http://www.stada.de |
| Updated |
07/08/2019 |
| STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the Generics and Branded Products segments. The Generics segment produces and distributes generic drugs. |
